Interleukin-2 and Regulatory T Cells in Rheumatic Diseases

Restoration of Treg cell fitness and/or expansion of their numbers using low-dose natural IL-2, the main cytokine driving Treg cell survival and function, has demonstrated clinical efficacy in early clinical trials.